Abstract
We report a case of a fetus with shortened proximal long bones, ambiguous genitalia, intrauterine growth restriction and abnormal umbilical artery Doppler velocities observed on antenatal ultrasound exam. At 34 weeks the patient revealed methotrexate/misoprostol exposure at 6 weeks gestational age in attempted medical termination of pregnancy. On newborn exam, the baby had dysmorphic facial features, a short torso, scoliosis, a micropenis (phallus <1 cm) and shortened proximal long bones both upper and lower extremities. X-ray exam revealed a hemivertebra at T10 level, rib abnormalities, shortened proximal long bones, an absent pubic bone and bilateral knee ossification centers. With methotrexate exposure, improved counseling and surveillance could potentially avoid these significant abnormalities and prevent psychological distress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nguyen CN, Duhl AJ, Escallon CS, Blakemore KJ . Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol 2002; 99: 599–602.
Warkany J, Beaudry PH, Hornstein S . Attempted abortion with aminopterin (4-aminopteroylglutamic acid). Am J Dis Child 1959; 97: 274–281.
Milunsky A, Graef JW, Gaynor MF . Methotrexate-induced congenital malformations. With a review of the literature. J Pediatr 1968; 72: 790–795.
Buckley LM, Bullaboy CA, Leichtman L, Marquez M . Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997; 40: 971–973.
Addar MH . Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report. J Obstet Gynaecol Can 2004; 26: 1001–1003.
Gonzalez CH, Marques-Dias MJ, Chong AK, Sugayama SM, De Paz JA, Huson SM et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998; 351: 1624–1628.
Chapa JB, Hibbard JU, Weber EM, Abramowicz JS, Verp MS . Prenatal diagnosis of methotrexate embryopathy. Obstet Gynecol 2003; 101: 1104–1107.
Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Descotes J, French Network of Regional Pharmacovigilance Centers. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol 2004; 31 (12): 2360–2365.
Schaff EA, Penmetsa U, Eisinger SH, Franks P . Methotrexate. A single agent for early abortion. J Reprod Med 1997; 42: 56–60.
Goldberg AB, Greenberg MB, Darney PD . Misoprostol and pregnancy. N Engl J Med 2001; 344 (1): 38–47.
Yedlinsky NT, Morgan FC, Whitecar PW . Anomalies associated with failed methotrexate and misoprostol termination. Obstet Gynecol 2005; 105: 1203–1205.
Feldkamp M, Carey JC . Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. Teratology 1993; 47: 533–539.
http://www.fda.gov/cder/drug/infopage/mifepristone/default.htm.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goffman, D., Cole, D., Bobby, P. et al. Failed methotrexate termination of pregnancy: a case report. J Perinatol 26, 645–647 (2006). https://doi.org/10.1038/sj.jp.7211563
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211563
Keywords
This article is cited by
-
Successful selective reduction of a heterotopic cesarean scar pregnancy in the second trimester: a case report and review of the literature
BMC Pregnancy and Childbirth (2016)
